A Discrepancy: Calcium Channel Blockers Are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart Failure

• Published in: Medical principles and practice Vol. 31; no. 5; pp. 454 - 462
• Main Authors: Koracevic, Goran, Perisic, Zoran, Stanojkovic, Maja, Stojanovic, Milovan, Zdravkovic, Milos, Tomasevic, Miloje, Djordjevic, Dragan, Mladenovic, Katarina, Koracevic, Maja, Trkulja, Jelena
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 01.12.2022
• Subjects: Antihypertensive Agents - therapeutic use; Antihypertensives; Blood pressure; Calcium Channel Blockers - therapeutic use; Cardiovascular disease; Diuretics; Drugs; Ejection fraction; Heart attacks; Heart failure; Heart Failure - complications; Heart Failure - drug therapy; Heart Failure - prevention & control; Humans; Hypertension; Hypertension - complications; Hypertension - drug therapy; Hypertension - epidemiology; Hypertrophy, Left Ventricular - drug therapy; Hypertrophy, Left Ventricular - prevention & control; Mortality; Original Paper; Prevention; Risk factors; Heart failure; Arterial hypertension; Renin-angiotensin-aldosterone system; Calcium channel blockers; Left ventricular hypertrophy

Arterial hypertension (HTN) is important due to its high prevalence, morbidity, and mortality rates. Calcium channel blockers (CCBs) are the first-line antihypertensive drugs. HTN can lead to heart failure (HF) by causing hypertensive left ventricular hypertrophy (HTN LVH). CCBs are recommended for...